Iovance Biotherapeutics to Report Third-Quarter Results Nov. 5
Iovance Biotherapeutics said it will report third-quarter 2026 financial results and corporate updates on Thursday, November 5, 2026.
Related stories
TFS Financial Reports Quarterly Results
TFS Financial Corp reported results for the quarter ended September 30.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC
FirstCash Shares Decline 14.75% as Law Firm Investigates Potential Securities Fraud
The Law Offices of Frank R. Cruz says it continues investigating potential securities fraud after a 14.75% decline in FirstCash Holdings shares.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC
First Northern Reports Higher Third-Quarter Net Profit
First Northern said net profit rose in the third quarter of 2026 compared with the previous quarter.
M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC
Innovotech Secures $600,000 in Credit Facilities From ATB Financial
Innovotech said it established a banking partnership with ATB Financial, securing $600,000 in credit facilities to support growth.
M impact | EQUITY | Oct 29, 2026, 11:55 PM UTC
Mastercard quarterly profit tops estimates
Reuters reports Mastercard's quarterly profit exceeded expectations, citing resilient consumer spending.
M impact | EQUITY | Oct 29, 2026, 11:54 PM UTC
Vale Reports Record Third-Quarter Production at Salobo
Vale reported record production for a third quarter at Salobo.
L impact | EQUITY | Oct 29, 2026, 11:54 PM UTC